Effect of highly active antiretroviral therapy on the clinical onset of AIDS defined by clinical episodes

Medicina Clinica

Volumn 118, Issue 18, 2002, Pages 686-688

  Fernández Rivera, Javier ^a   Macías, Juan ^a   García García, José Ángel ^a   Ramos, Antonio Javier ^a   Leal, Manuel ^b   Pineda, Juan Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

AIDS; Opportunistic infections; Visceral leishmaniansis

Indexed keywords

COTRIMOXAZOLE; ISONIAZID; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; PROSPECTIVE STUDY; TUBERCULOSIS; VISCERAL LEISHMANIASIS; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS;

EID: 0037129758     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72497-4     Document Type: Article

References (17)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Changing patterns of mortality across Europe in patients infected with HIV-1
3. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
4. Immune reconstitution in AIDS: Oncologic implications and hematologic implications
5. Descenso de la incidencia de tuberculosis siguiendo la introducción de los nuevos tratamientos frente al VIH
6. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of high active antiretroviral theraphy
7. Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in HIV-infected patients
8. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults
9. Epidemiological surveillance of leishmaniasis in HIV-1 infected individuals in Italy
10. Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1 infected patients in Southern Spain
11. Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of the highly active antiretroviral therapy
12. Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus
13. Cambios en la vía de administración de la heroína y frecuencia de infección por el virus de la inmunodeficiencia humana
14. Injecting drug use as risk factor for visceral leishmaniasis in AIDS patients
15. Evidence of an increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain
16. Effectiveness of isoniazid chemoprophylaxis for HIV-infected drugs users at high risk for active tuberculosis
17. Influencia de la actuación médica sobre la forma de presentación del sida definido por episodios clinicos